Creatine supplementation prevents the inhibition of myogenic differentiation in oxidatively injured C2C12 murine myoblasts.
about
The beneficial role of proteolysis in skeletal muscle growth and stress adaptationCytotoxic and Antitumor Activity of Sulforaphane: The Role of Reactive Oxygen SpeciesTestosterone plus low-intensity physical training in late life improves functional performance, skeletal muscle mitochondrial biogenesis, and mitochondrial quality control in male miceThe role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymesCreatine-induced activation of antioxidative defence in myotube cultures revealed by explorative NMR-based metabonomics and proteomics.Concurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients.Morphofunctional and Biochemical Approaches for Studying Mitochondrial Changes during Myoblasts Differentiation.A novel splice variant of folate receptor 4 predominantly expressed in regulatory T cells.The pleiotropic effect of physical exercise on mitochondrial dynamics in aging skeletal muscle.Reactive oxygen species in skeletal muscle signaling.Effects of acute creatine supplementation on iron homeostasis and uric acid-based antioxidant capacity of plasma after wingate test.Disruption of nuclear factor (erythroid-derived-2)-like 2 antioxidant signaling: a mechanism for impaired activation of stem cells and delayed regeneration of skeletal muscleCreatine as an antioxidant.Mitohormesis in muscle cells: a morphological, molecular, and proteomic approach.New insights into the trophic and cytoprotective effects of creatine in in vitro and in vivo models of cell maturation.Creatine Prevents the Structural and Functional Damage to Mitochondria in Myogenic, Oxidatively Stressed C2C12 Cells and Restores Their Differentiation Capacity.Identification of the immunoproteasome as a novel regulator of skeletal muscle differentiation.Hypoxia decreases creatine uptake in cardiomyocytes, while creatine supplementation enhances HIF activation.Protective effect of different antioxidant agents in UVB-irradiated keratinocytes.Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model.Effects of a co-treatment with pyruvate and creatine on dendritic spines in rat hippocampus and posterodorsal medial amygdala in a phenylketonuria animal model.The Combination of Physical Exercise with Muscle-Directed Antioxidants to Counteract Sarcopenia: A Biomedical Rationale for Pleiotropic Treatment with Creatine and Coenzyme Q10.Creatine supplementation reduces doxorubicin-induced cardiomyocellular injury.Diabetes-Induced Dysfunction of Mitochondria and Stem Cells in Skeletal Muscle and the Nervous System.Altered in vitro proliferation of mouse SOD1-G93A skeletal muscle satellite cells.Creatine supplementation to total parenteral nutrition improves creatine status and supports greater liver and kidney protein synthesis in neonatal piglets.Creatine affects in vitro electrophysiological maturation of neuroblasts and protects them from oxidative stress.Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.CadF expression in Campylobacter jejuni strains incubated under low-temperature water microcosm conditions which induce the viable but non-culturable (VBNC) state.Myoprotective Potential of Creatine Is Greater than Whey Protein after Chemically-Induced Damage in Rat Skeletal Muscle.Effects of creatine in a rat intestinal model of ischemia/reperfusion injury
P2860
Q26750990-B89CAFD9-E61D-4C37-A13F-979A3340DDD2Q26799560-CA34DA4D-D4E8-4C58-8743-392278178DCAQ27332135-F6EE82E8-258A-4055-92AC-A5DCCBB5C892Q28076877-7F1A4D32-F86A-415F-AEFA-89C4E4C70E18Q33657909-2B58C95E-9BA9-440B-966D-4FE805C1C573Q33872738-9D75F3AC-0F83-4242-A063-DD668B089F42Q33918285-7BA0B480-BEB6-43D6-8158-4D1661C431E6Q34302945-5D82D814-286E-4D27-929D-E671BDC5BE77Q35471306-1889BE0B-BD81-44FE-9190-5FC29125071AQ35607438-2E914B06-9C90-4D01-9711-533BB458BAB2Q36226601-79681F4F-8A6E-4946-AB77-9C85BA46742DQ36812068-7A24C953-9E40-4552-BB08-53CC133A81CBQ37853058-9F2570A6-C0F8-4284-83F5-631072055C7BQ38193443-4FA26101-E65F-4953-B271-B0F6C38E18F1Q38685353-D347B1E7-0B54-44BA-B86C-2DBF209E686AQ38747479-A45E4BC3-3886-468E-BB7B-20C7A4DB7501Q39069554-A237083B-8E28-4687-BCFC-6EC3D589457BQ41600066-52ABFE85-A742-4882-9C8A-814027396560Q42365556-9A481822-D0BC-4901-8F4F-5527E4C0FA98Q43184352-A0B33362-7865-4633-8E34-BA8BA0828921Q45384723-560C4D57-77F2-4287-B517-9B40D43EA5FDQ45833603-8D1D907C-C714-4D6E-BE34-1FC688806496Q46834237-7CA101E3-7CA7-4628-8475-4E2C27683148Q47130139-054EDD17-97C3-4A31-A370-77A7C0896005Q47383532-11DFE842-9BD4-400E-80F1-7168AC1D7808Q47896823-33566FD2-A57E-4ED0-8E79-A06F9D1954BFQ48879217-28667372-58C8-4CFE-8B75-5D9CBE7C2D35Q52582224-51C2532D-B710-48A8-B47D-FFA18C4DAFC5Q53124910-0939FD14-9A16-4CBE-B79F-CD7794B9CD60Q55035476-8A576612-D6C1-4DB6-A8ED-DB715844F4A7Q57117530-85282DD2-31C0-48B6-B8E4-C2FE035E520C
P2860
Creatine supplementation prevents the inhibition of myogenic differentiation in oxidatively injured C2C12 murine myoblasts.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Creatine supplementation preve ...... njured C2C12 murine myoblasts.
@en
Creatine supplementation preve ...... njured C2C12 murine myoblasts.
@nl
type
label
Creatine supplementation preve ...... njured C2C12 murine myoblasts.
@en
Creatine supplementation preve ...... njured C2C12 murine myoblasts.
@nl
prefLabel
Creatine supplementation preve ...... njured C2C12 murine myoblasts.
@en
Creatine supplementation preve ...... njured C2C12 murine myoblasts.
@nl
P2093
P2860
P50
P356
P1476
Creatine supplementation preve ...... njured C2C12 murine myoblasts.
@en
P2093
Alessandra D'Emilio
Anna Maria Gioacchini
Chiara Martinelli
Lucia Casadei
Marco Paolillo
Michela Battistelli
Vilberto Stocchi
P2860
P304
P356
10.1002/MNFR.200800504
P50
P577
2009-09-01T00:00:00Z